

Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Excerpt Primary vaccination with Beta-containing vaccine candidate delivers 64.7% efficacy against symptomatic infection in adults, and 75.1% efficacy in participants previously infected with COVID-19Article Summary Sequencing analysis has shown 72 percent efficacy against Omicron in adults overall and 93.2 percent in seropositives. Favorable safety and tolerability profile First-ever efficacy findings in an Omicron setting indicate […]


LOTTE BIOLOGICS Signs MoU with MilliporeSigma for Strategic Partnership
Excerpt Lotte Group has named MilliporeSigma as its preferred bioprocess vendor to support its burgeoning US-based CDMO business. Article Summary LOTTE BIOLOGICS, new biologics business of LOTTE group, signed a Memorandum of Understanding (MoU) with MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, outlining […]


BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
Excerpt The first container modules are expected to be delivered by the end of 2022 from Kigali, Rwanda, the site of BioNTech’s first African modular mRNA manufacturing factory. The facility will come with two BioNTainers initially, and it is anticipated that by 2024, there will be roughly 100 employees working there. BioNTech’s malaria vaccine candidates […]


WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore
Excerpt A cutting-edge, fully integrated CRDMO center of WuXi Biologics will be developed in Singapore, including a large-scale drug substance and drug product manufacturing facility. Article Summary With a 10-year investment plan worth USD$1.4 billion (S$2 billion), WuXi Biologics, a global leader in Contract Research, Development and Manufacturing (CRDMO), will expand its research, development, and […]

